Clarithromycin (Biaxin)
1751
relevant articles (290 outcomes,
281 trials/studies)
found for this Drug
Description:
A semisynthetic macrolide antibiotic derived from ERYTHROMYCIN that is active against a variety of microorganisms. It can inhibit protein synthesis in bacteria by reversibly binding to the 50S ribosomal subunits. This inhibits the translocation of aminoacyl transfer-RNA and prevents peptide chain elongation.
Also Known As:
Biaxin; 6-O-Methylerythromycin; A-56268; TE-031; A 56268; A56268; TE 031; TE031; Erythromycin, 6-O-methyl-
Relationship Network
Drug Context: Research Results